jcm-logo

Journal Browser

Journal Browser

Current and Emerging Treatment Options in Chronic Liver Diseases

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Gastroenterology & Hepatopancreatobiliary Medicine".

Deadline for manuscript submissions: 28 February 2026 | Viewed by 23

Special Issue Editor


E-Mail Website
Guest Editor
1. Department of Pharmacology, Biomedicine Discovery Institute, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, VIC 3800, Australia
2. Department of Surgery, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Heidelberg, VIC 3084, Australia
Interests: liver diseases; liver fibrosis; liver cirrhosis; portal hypertension; liver cancer; diabetic liver diseases

Special Issue Information

Dear Colleagues,

Liver fibrosis is initiated as a part of the wound healing response to tissue injury. The most common injurious agents for chronic liver disease (CLD) include chronic viral infections (e.g., hepatitis B and C), excessive alcohol consumption, metabolic dysfunction-associated steatotic liver disease (MASLD), and cholestatic diseases such as primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC). The end result of chronic injury to the liver is cirrhosis, in which there is extensive scar formation, distortion of the liver parenchyma by septae and nodule formation, and alterations in blood flow. Cirrhosis can be associated with the development of liver cancer, leading to liver failure and death. Thus, cirrhosis, and its major life-threatening complications of portal hypertension (PHT) and variceal bleeding, as well as liver cancer are responsible for a large number of deaths worldwide annually. However, the treatment options for CLD and liver cancer are limited. Therefore, there is a major unmet need for the development of more effective and better-tolerated treatments for CLD, including liver cancer. To address these areas, the Journal of Clinical Medicine has set up this Special Issue for potential authors to highlight recent advances in the diagnosis and treatment of CLD, including liver cancer, through clinical research. We therefore invite authors to contribute with highly innovative original papers or critical reviews in this field.

Dr. Chandana B. Herath
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • liver disease
  • liver fibrosis
  • liver cirrhosis
  • portal hypertension
  • liver cancer
  • therapies
  • immunological therapies for liver cancer
  • diabetic liver
  • type 2 diabetes and obesity
  • spontaneous bacterial peritonitis

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop